News Archive

2021

January

Media Release / Jan 15, 2021

Novartis ligelizumab (QGE031) receives FDA Breakthrough Therapy designation for patients with chronic idiopathic urticaria (CIU)

Read More
2020

December

Novartis researchers are working together on a task
Story / Dec 21, 2020

Working Together at Novartis to Fight COVID-19 and Help People in Need

Novartis is fighting COVID-19 broadly, from committing R&D resources to better understand and treat the disease to reaching out to individuals and communities in need.

Read More
Media Release / Dec 15, 2020

Novartis announces positive FDA Advisory Committee recommendation for use of Entresto® to treat patients with HFpEF

Read More
Media Release / Dec 09, 2020

Novartis Kisqali® demonstrates nearly five years median overall survival in metastatic breast cancer

Read More
Media Release / Dec 08, 2020

Novartis investigational STAMP inhibitor asciminib (ABL001) shows superior MMR rate to Bosulif®* in chronic myeloid leukemia trial

Read More
Media Release / Dec 07, 2020

Novartis and Amgen partner with Karamo Brown to support and empower people living with migraine

Read More
Media Release / Dec 01, 2020

Novartis announces FDA approval of Xolair® (omalizumab) for adults with nasal polyps

Read More

April

Media Release / Apr 30, 2020

Novartis US Foundation supports telehealth programs to provide access to care for New Jersey's most vulnerable communities

Read More

November

Media Release / Nov 19, 2020

New data at ASH to reinforce breadth of Novartis hematology portfolio across multiple blood cancers and serious hematologic diseases

Read More

Related Links